These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 7628755)

  • 1. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of chronic lymphocytic leukemia.
    Han T; Rai KR
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
    Montserrat E; Bosch F; Rozman C
    J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic lymphatic leukemia].
    Lechner K; Bilbeisi S; Wittmann E; Wilfing A
    Wien Klin Wochenschr; 1994; 106(10):291-9. PubMed ID: 8053196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia: staging and prognostic factors.
    Zwiebel JA; Cheson BD
    Semin Oncol; 1998 Feb; 25(1):42-59. PubMed ID: 9482526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S
    Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
    Molica S; Levato D; Dattilo A
    Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
    Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
    Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic lymphatic leukemia].
    Adam Z; Vorlícek J; Hejlová N
    Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
    Bergmann L
    Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
    Dhodapkar M; Tefferi A; Su J; Phyliky RL
    Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages.
    Montserrat E; Viñolas N; Reverter JC; Rozman C
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):359-61. PubMed ID: 3222145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.